Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

Psychopharmacology

Volumn 180, Issue 4, 2005, Pages 724-734

  Risterucci, Céline ^a   Jeanneau, Karine ^a   Schöppenthau, Stephanie ^a   Bielser, Thomas ^a   Künnecke, Basil ^a   Von Kienlin, Markus ^a   Moreau, Jean Luc ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Animal model; Hippocampal lesion; MRI; Phencyclidine; Schizophrenia

Indexed keywords

PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN REGION; BRAIN SLICE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ENTORHINAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; HIPPOCAMPUS; MALE; NEUROANATOMY; NEUROIMAGING; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PERFUSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRIFORM CORTEX; QUANTITATIVE ANALYSIS; RAT; SCHIZOPHRENIA; SPIN LABELING; STARTLE REFLEX; STRIA TERMINALIS; TEMPORAL CORTEX;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; IMAGE PROCESSING, COMPUTER-ASSISTED; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MALE; MODELS, NEUROLOGICAL; OXYGEN; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SCHIZOPHRENIA; STARTLE REACTION;

EID: 24944592462     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2204-8     Document Type: Article

References (66)

1. Al-Amin HA, Weinberger DR, Lipska BK (2000) Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacol 11:269-278
2. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Ponto LLB, Hichwa RD (1997) Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 349:1730-1734
3. Aslop DC, Detre JA (1996) Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 16:1236-1249
4. Barbier EL, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13(4):496-520
5. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naïve patients with schizophrenia. Arch Gen Psychiatry 58:280-288
6. Benes FM, Berretta S (2000) Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann NY Acad Sci 911:293-304
7. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR (1997) Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporolimbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 7:740-748
8. Bertolino A, Roffman JL, Lipska BK, van Gelderen P, Olson A, Weinberger DR (2002) Reduced N-acetylaspartate in prefrontal cortex of adult rats with neonatal hippocampal damage. Cereb Cortex 12:983-990
9. Braus DF, Brassen S, Weimer E, Tost H (2003) Functional magnetic resonance imaging of psychopharmacological brain effects: an update. Fortschr Neurol Psychiatr 71:72-83
10. Bunney WE, Bunney BG (2000) Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Rev 31:138-146
11. Chambers RA, Moore JM, McEvoy JP, Levin ED (1996) Cognitive effects of neonatal hippocampal lesions in rat model of schizophrenia. Neuropsychopharmacology 15:587-594
12. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS, Watkins GL, Ponto LLB, Hichwa RD (2001) Neural mechanisms of anhedonia in schizophrenia. JAMA 286:427-435
13. Curtis VA, Bullmore ET, Morris RG, Brammer MJ, Williams SC, Simmons A, Sharma T, Murray RM, McGuire PK (1999) Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res 37:35-44
14. Deichmann R, Hahn D, Haase A (1999) Fast T1 Mapping on a whole-body scanner. Magn Reson Med 42:206-209
15. Detre DJ, Wang J (2002) Technical aspects and utility of fMRI using BOLD and ASL. Magn Reson Med 48:242-254
16. Fuster JM (1997) The prefrontal cortex: anatomy, physiology and neuropsychology of the frontal lobe, 3rd edn. Raven-Lippincott, Philadelphia
17. Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 56:21-27
18. Groenewegen HJ, Berendse HW (1994) The specificity of the 'nonspecific' midline and intralaminar thalamic nuclei. Trends Neurosci 17:52-57
19. Haase A, Frahm J, Matthaei D, Hänicke W, Merboldt KD (1986) FLASH imaging. Rapid NMR imaging using low flip-angle pulses. J Magn Reson 67:258-266
20. Harrison PJ (1999) The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 122:593-624
21. Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11:520-528
22. Heeger DJ, Ress D (2002) What does fMRI tell us about neuronal activity? Nat Rev Neurosci 3:142-151
23. Heinz A, Romero B, Gallinat J, Juckel G, Weinberger DR (2003) Molecular brain imaging and the neurobiology and genetics of schizophrenia. Pharmacopsychiatry 36(Suppl 3):S152-S175
24. Heresco-Levy U, Javitt DC (2004) Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr Res 66:89-96
25. Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR (2001) Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol 4:385-391
26. Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H (2004) Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor glycine-site agonists. Neuropsychopharmacology 29:300-307
27. Jentsch JD, Taylor JR, Elsworth JD, Redmond DE Jr, Roth RH (1999) Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits. Neuroscience 90:823-832
28. Kasai K, Iwanami A, Yamasue H, Kuroki N, Nagakome K, Fukuda M (2002) Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 43:93-110
29. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist ketamine in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
30. Lahti AC, Koffel B, Laporte D, Tamminga CA (1994) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
31. Le Bihan D (1996) Functional MRI of the brain principles, applications and limitations. J Neuroradiol 23:1-5
32. Le Pen G, Grottick AJ, Higgins GA, Martin JR, Jenck F, Moreau J-L (2000) Spatial and associative learning deficits induced by neonatal excitotoxic hippocamapl damage in rats: further evaluation of an animal model of schizophrenia. Behav Pharmacol 11:257-268
33. Le Pen G, Gaudet L, Mortas P, Mory R, Moreau JL (2002) Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology 161:434-441
34. Leslie RA, James MF (2000) Pharmacological magnetic resonance imaging: a new application for functional MRI. TIPS 21:314-318
35. Lillrank SM, Lipska BK, Kolachana BS, Weinberger DR (1999) Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage. J Neural Transm 106:183-196
36. Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23:223-239
37. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75
38. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR (1995a) Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 20:125-130
39. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995b) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35-43
40. Lukasik VM, Gillies RJ (2003) Animal anaesthesia for in vivo magnetic resonance. NMR Biomed 16(8):459-467
41. Magistretti PJ, Pellerin L (1999) Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond, B Biol Sci 354:1155-1163
42. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL (2000) Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48:99-109
43. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Faith Berman K (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5:267-271
44. Niznikiewicz MA, Kubicki M, Shenton ME (2003) Recent structural and functional imaging findings in schizophrenia. Curr Opin Psychiatry 16:123-147
45. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK (2002) Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12:975-982
46. Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87:9868-9872
47. Paxinos G, Watson C (1986) The rats brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
48. Pearlson GD (2000) Neurobiology of schizophrenia. Ann Neurol 48:556-566
49. Rund BR, Borg NE (1999) Cognitive deficits and cognitive training in schizophrenic patients: a review. Acta Psychiatr Scand 100:85-95
50. Russell TA, Rubia K, Bullmore ET, Soni W, Suckling J, Brammer MJ, Simmons A, Williams SC, Sharma T (2000) Exploring the social brain in schizophrenia: left prefrontal underactivation during mental state attribution. Am J Psychiatry 157:2040-2042
51. Salmeron BJ, Stein EA (2002) Pharmacological applications of magnetic resonance imaging. Psychopharmacol Bull 36:120-129
52. Sams-Dodd F (1999) Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Rev Neurosci 10:59-90
53. Schultz SK, Andreasen NC (1999) Schizophrenia. Lancet 353:1425-1430
54. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001) A review of MRI findings in schizophrenia. Schizophr Res 49:1-52
55. Silva AC, Kim S-G (2003) Perfusion-based functional magnetic resonance imaging. Concepts Magn Reson 16A:16-27
56. Silva AC, Zhang W, Williams DS, Koretsky (1995) Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labelling. MRM 33:209-214
57. Thompson PM, Vidal C, Giedd JN (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early schizophrenia. Proc Natl Acad Sci USA 98:11651-11655
58. Tsacopoulos M, Magistretti PJ (1996) Metabolic coupling between glia and neurons. J Neurosci 16(3):877-885
59. Turner R, Jones T (2003) Techniques for imaging neuroscience. Br Med Bull 65:3-20
60. Uehara T, Tanii Y, Sumiyoshi T, Kurachi M (2000) Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain. Brain Res 860:77-86
61. Velakoulis D, Pantelis C (1996) What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Aust N Z J Psychiatry 30:195-209
62. Weinberger DR, Berman KF, Zee RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-124
63. Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 89:212-216
64. Witter MP, Wouterlood FG, Naber PA, van Haeften T (2000) Anatomical organization of the parahippocampal-hippocampal network. Ann NY Acad Sci U S A 911:1-24
65. Woodruff PW, Wright IC, Bullmore ET, Brammer M, Howard RJ, Williams SC, Shapleske J, Rossell S, David AS, McGuire PK, Murray (1997) Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. Am J Psychiatry 154:1676-1682
66. Wolterink G, Daenen L, Dubbeldam S, Gerrists M, van Rijn R, Kruse C, van der Heijden J, van Ree J (2001) Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur Neuropsychopharmacol 11:51-59